Factor | Total (N = 261) (100%) | ALL (A) (N = 70) (26.8%) | APL (B) (N = 24) (9.2%) | AML (C) (N = 167) (64.0%) | P | P for multiple comparisons | ||
---|---|---|---|---|---|---|---|---|
A vs. B | A vs. C | B vs. C | ||||||
Sex | Â | Â | Â | Â | 0.314 | 0.151 | 0.280 | 0.398 |
 -Female | 125 (47.9%) | 29 (41.4%) | 14 (58.3%) | 82 (49.1%) |  |  |  |  |
 -Male | 136 (52.1%) | 41 (58.6%) | 10 (41.7%) | 85 (50.9%) |  |  |  |  |
Median age (IQR) (years) | 49 (35–61) | 35 (22–58) | 43 (34–48) | 55 (40–63) |  < 0.001 | 0.336 |  < 0.001 | 0.001 |
Clinical features of major bleeding (WHO grade 4) | ||||||||
 -Oropharyngeal | 4 (1.5%) | 4 (5.7%) | 0 (0%) | 0 (0%) |  |  |  |  |
 -Epistaxis | 3 (1.1%) | 2 (2.9%) | 0 (0%) | 1 (0.6%) |  |  |  |  |
 -Hemoptysis | 5 (1.9%) | 1 (1.4%) | 1 (4.2%) | 3 (1.8%) |  |  |  |  |
 -UGIB | 7 (2.7%) | 2 (2.9%) | 0 (0%) | 5 (3.0%) |  |  |  |  |
 -LGIB | 6 (2.3%) | 3 (4.3%) | 0 (0%) | 3 (1.8%) |  |  |  |  |
 -Hematuria | 4 (1.5%) | 3 (4.3%) | 1 (4.2%) | 0 (0%) |  |  |  |  |
 -Vaginal bleeding | 4 (1.5%) | 1 (1.4%) | 2 (8.2%) | 1 (0.6%) |  |  |  |  |
 -Muscle hematoma | 1 (0.4%) | 0 (0%) | 1 (4.2%) | 0 (0%) |  |  |  |  |
 -Retinal hemorrhage | 8 (3.1%) | 5 (7.1%) | 0 (0%) | 3 (1.8%) |  |  |  |  |
 -Intracerebral hemorrhage | 8 (3.1%) | 1 (1.4%) | 2 (8.3%) | 5 (3.0%) |  |  |  |  |
 -Overall bleeding events (numbers of patients) | 50 (44 patients) | 22 (18 patients) | 7 (6 patients) | 21 (20 patients) | 0.019 | 0.945 | 0.009 | 0.107 |
Clinical features of thrombosis | ||||||||
 -Deep vein thrombosis | 2 (0.8%) | 0 (0%) | 0 (0%) | 2 (1.2%) |  |  |  |  |
 -Pulmonary embolism | 5 (1.9%) | 1 (1.4%) | 2 (8.3%) | 2 (1.2%) |  |  |  |  |
 -Acute arterial occlusion | 1 (0.4%) | 0 (0%) | 1(4.2%) | 0 (0%) |  |  |  |  |
 -Splenic infarction | 2 (0.8%) | 0 (0%) | 0 (0%) | 2 (1.2%) |  |  |  |  |
 -Acute cerebral infarction | 7 (2.7%) | 2 (2.9%) | 0 (0%) | 5 (3.0%) |  |  |  |  |
 -Overall thrombotic events (numbers of patients) | 17 (16 patients) | 3 (3 patients) | 3 (2 patients) | 11 (11 patients) | 0.719 | 0.599 | 0.763 | 0.670 |
Laboratory at diagnosis | ||||||||
 Mean ± SD | ||||||||
  -Hemoglobin (g/L) | 78 ± 23 | 87 ± 24 | 84 ± 23 | 74 ± 21 |  < 0.001 | 0.582 |  < 0.001 | 0.035 |
 Median (IQR) | ||||||||
  -WBC (× 109/L) | 18.50 (3.96–95.50) | 26.72 (4.30–116.63) | 4.66 (1.20–26.09) | 18.27 (4.52–86.31) | 0.012 | 0.008 | 0.476 | 0.005 |
  -Platelet (× 109/L) | 40.00 (18.00–81.00) | 50.50 (21.00–94.00) | 33.00 (20.00–49.00) | 37.00 (16.00–73.00) | 0.297 | 0.151 | 0.210 | 0.554 |
  -PT (seconds) | 14.0 (13.0–15.6) | 13.6 (12.5–15.3) | 14.1 (13.4–16.8) | 14.0 (13.1–15.6) | 0.189 | 0.130 | 0.127 | 0.467 |
  -APTT (seconds) | 26.1 (23.8–29.4) | 26.9 (23.9–28.9) | 25.5 (23.8–30.2) | 25.8 (23.5–29.5) | 0.928 | 0.745 | 0.725 | 0.976 |
  -Fibrinogen (mg/dL) | 349 (247–453) | 338 (219–436) | 153 (123–287) | 372 (272–484) |  < 0.001 |  < 0.001 | 0.044 |  < 0.001 |
  -D-dimer (µg FEU/L) | 3,259.1 (1,120.0–8,492.5) | 4,034.7 (1,338.6–9,145.9) | 9,308.5 (5,490.2–10,000.0) | 2,394.4 (967.5–6,502.0) |  < 0.001 | 0.001 | 0.057 |  < 0.001 |
Median ISTH-DIC scores | 3 (2–5) | 3 (1–5) | 5 (4–6) | 3 (2–4) |  < 0.001 | 0.001 | 0.479 |  < 0.001 |
Numbers of overt DIC | 75 (28.7%) | 20 (28.6%) | 15 (62.5%) | 40 (24.0%) |  < 0.001 | 0.003 | 0.456 |  < 0.001 |